The value of echocardiography for prediction of radiation-induced lung injury in non-small cell lung cancer patients treated with chemo radiation: an onco-cardiac prospective cohort study.
Completed
- Conditions
- malignant lungtumournon-small lung cancer stage I-III1008220610029107
- Registration Number
- NL-OMON47174
- Lead Sponsor
- MAASTRO clinic
- Brief Summary
Trial ended prematurely
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
* Clinical stage I-III non-small cell lung cancer
* Planned for curatively intended primary (chemo)radiotherapy, due to irresectable disease and/or medical inoperability
* WHO performance status 0-2
* No history of prior chest radiotherapy
* No uncontrolled infectious disease
* No other active malignancy
* No prior lung surgery
* Willing and able to comply with the study prescriptions
* 18 years or older
* Ability to give and having given written informed consent before patient registration
Exclusion Criteria
* WHO performance status >2
* History of prior chest radiotherapy
* Uncontrolled infectious disease
* Other active malignancy
* Prior lung surgery
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p> Main study parameter/endpoint:<br /><br>* Dyspnea score at three months after (chemo)radiotherapy, assessed by the<br /><br>patient version of the CTCv4.</p><br>
- Secondary Outcome Measures
Name Time Method